The most-studied healing peptide in the space has one honest problem: the evidence is strong in animals and thin in humans. Here's the full, unvarnished picture — what the preclinical data shows, what the side-effect list actually contains, and what grade D evidence means before you buy.
The molecule and the mechanism, from the product page.
It speeds up the body's repair machinery at an injury — more new blood vessels, more collagen, calmer inflammation — in gut, tendon, ligament and skin. That's why it's the go-to in wound and connective-tissue research circles.
BPC-157 (Body Protection Compound) is a 15-amino-acid gastric pentadecapeptide derived from a protective stomach protein. Mechanistically it's a pro-angiogenic cascade — VEGF/VEGFR2, eNOS/NO signalling, FAK/integrin, collagen deposition — that modulates chronic inflammation (iNOS) without suppressing vasodilation (eNOS).
This is the section most 'results' content skips. It's the whole reason this is a research peptide.
Strong, consistent preclinical data — rodent wound-closure and cartilage studies. The mechanism work (angiogenesis, collagen deposition, inflammation modulation) is well-replicated in animal models.
Very few controlled human trials yet. Grade D on the product page's own scale. That's not a weakness to argue away — it's the niche the product serves: research-grade, for researchers, ahead of the human data.
From the product page. Shorter list than the GLP-1 class — with one theoretical caution to know about.
In animal and observational use, tolerance is the headline. That's the honest base rate — it's a healing peptide, not a class with a GI reputation.
The common one. Local to the injection — the same category as any injectable, and why local-to-injury use is the typical pattern.
In vascular/tumour-prone cases, the pro-angiogenic mechanism is the reason to pause and think. Unproven as a side effect — it's a caution from the mechanism, and the product page labels it exactly that.
From the product page — typical research/clinical ranges, not a prescription.
| Parameter | Typical research range | Note |
|---|---|---|
| Dose | 250–500 µg/day | Daily, not weekly — a different cadence from the GLP-1 class. |
| Route | Often local to the injury | The typical pattern in the research use described on the product page. |
| Cycle | 8–16 weeks | Course-based, not indefinite. |
Per-vial pricing, two payment paths, same delivery as the rest of the range.
5 mg and 10 mg vials, from £9.35 — order one vial or a full course, the per-vial price is the same.
Same lot, same delivery, whole order 10% off. Quote your order number as the payment reference.
Every batch ships with its Certificate of Analysis — tracked, insured, UK-wide, next working day dispatch. WELCOME10 stacks on your first order.
One useful email when a vial needs replacing, plus the bits that save you the vial. No pressure, unsubscribe anytime.